Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ruck - Sorry, I'm with you now.
Viruses constantly mutate and shift, that's why the flu vaccine changes each year. So the ability to quickly adapt a vaccine to target new antigens is much more important when it comes to viruses. The issue with ImmunoBody is the length of time it takes to manufacture - too long perhaps for a vaccine tackling viruses.
Crumbs, yes that link is also at the bottom of my 16.01
The closest we got to an ImmunoBody flu vaccine https://immbio.net/uploads/documents/Poster_Fusion_Proteins_FluBioVax.pdf
Crumbs that's exactly the point i was making Samsung invested 60 million dollars in a company called cytodyn the funding for them came from an electronics company for Aids but also realised the science will work for cancer being a little over simplified perhaps but all the same the video worth a passing look. Here it is again https://youtu.be/J4A9k1blk60
Regards
On this as has been written it is not an area scancell themselves are currently able to take ImmunoBody forwards in and no collaborator took it forwards either but I wonder does the moving away from electroporation (Ichor) delivery to nano delivery make it a more attractive platform to any player who would like to take it on to tackle viruses.... I'm not expecting anything in that area myself though yeah the whole coronavirus situation makes it topical plus our old mates Inovio are very active in this area and managed to get some serious wonga off Bill Gates no less .
Bermuda, yes, I have never seen Scancell make a statement that would suggest this.
I was referring to comments made by posters on this board. It all seems a bit desperate to me.!
Ruck,
Why do you think that Scancell are looking to vaccines for aids and coronavirus to raise funds? AFAIK Scancell have been absolutely clear, they are only interested in developing cancer vaccines.
If you look at the first sentence on Scancell's home page it says:
"Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system."
Am I the only one who feels slightly perturbed that we are looking to vaccines for aids and coronavirus as the way to raise funds? What does that say about the prospects of raising funds from what we are supposed to be developing, namely, cancer treatments?
shareguard,
Probably not general knowledge but going back a few years, an ImmunoBody flu vaccine was developed as a result of a collaboration between Scancell and Cambridge based Immbio Therapeutics. As far as I know, the vaccine, FluBioVax didn't get as far as clinical trials and Immbio was closed down last year.
http://www.immbio.net/vaccines/exploratory-immunobodies
http://www.immbio.net/uploads/documents/Poster_Fusion_Proteins_FluBioVax.pdf
Erm forgot this
https://youtu.be/J4A9k1blk60
Funny enough i was thinking the same was researching another stock last night come across this video which was repeated on Bloomberg tv last night. Contains 3 stocks the middle one is seeing machines the one i hold, but watched them all the first one got a drug for aids in phase 3 and using similar for cancer not looked at the science but seems similar to scancell. What struck me was how well funded they are from Samsung of all people based in south korea if Scancells tech can be used for virus who knows the money could roll in from a source no one would have thought of, nothing like a crisis to loosen the purse strings you have to look at wars suddenly money is no object.
Regards
yes immunobody can be used against Virus ... but a Virus rarely needs the potency of immunobody
its also an expensive vaccine because of the extra cost of delivery compared to traditional virus vaccines ...
Sclp has historically stated this technology could be used for aids. Could it be used to fight Corono virus